Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN140,06140,10,21
Msft-1,34
Nokia10,8211,1153,27
IBM-0,67
Mercedes-Benz Group AG50,1350,06-0,38
PFE-3,02
09.05.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 08.05.2026 21:58:46
Nu Skin Enter (NUS, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
7,11 1,21 0,09 2 750 481
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 09.05.2026
Popis společnosti
Obecné informace
Název společnostiNU Skin Enterprises Inc
TickerNUS
TickerNUS.B
Kmenové akcie:Ordinary Shares Class A
Kmenové akcie:Ordinary Shares
RICNUS.B
RICNUS
ISIN-
Poslední známé roční výsledky31.12.2025
Poslední známé čtvrtletní výsledky31.03.2026
Počet zaměstnanců k 31.12.2025 2 800
Akcie v oběhu k 31.03.2026 49 176 734
MěnaUSD
Kontaktní informace
UliceATTN: D. MATTHEW DORNY
MěstoPROVO
PSČ84601
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon18 013 456 100
Fax13026365454

Business Summary: Nu Skin Enterprises, Inc. develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. It has nine segments, consisting of its seven geographic Nu Skin segments - Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan - and two Rhyz segments - Manufacturing and Rhyz Other. Its beauty & skincare solutions include acne and blemishes, anti-aging, dark circles and puffiness, discoloration, dry skin, lines and wrinkles, and oily skin and pores. Its health & wellness solutions include gut health, bone and joint health, brain health, energy and stamina, heart health, immunity support, and protein and fitness. It offers various beauty devices, including ageLOC LumiSpa, Nu Skin RenuSpa iO and Prysm iO. Its ageLOC LumiSpa includes products such as LumiSpa iO Superpower Kit, ageLOC Rose Gold LumiSpa iO, LumiSpa Rose Gold Accent Twin Pack, and others.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, NU Skin Enterprises Inc revenues decreased 14% to $1.49B. Net income totaled $160.2M vs. loss of $146.6M. Revenues reflect Nu Skin segment decrease of 13% to $1.26B, Rhyz other segment decrease of 79% to $17.8M. Net Income reflects Selling expenses decrease of 22% to $508.4M (expense), General and administrative expenses-bal decrease of 13% to $378.2M (expense).
Odvětvová klasifikace
TRBC2009Personal Products
TRBC2012Personal Products (NEC)
RBSS2004Personal Products
MGINDUSTRYMajor Drugs
MGSECTORHealthcare
NAICSDrugs and Druggists' Sundries Merchant Wholesalers
NAICSToilet Preparation Manufacturing
NAICS2007Drugs and Druggists' Sundries Merchant Wholesalers
NAICS2007Toilet Preparation Manufacturing
NAICS1997Drug, Drug Proprietaries and Druggists' Sundries Wholesalers
NAICS1997Toilet Preparation Manufacturing
SICDrugs/proprietaries/sundries
SICDrugs/proprietaries/sundries
SICToilet Preparations



  • Poslední aktualizace: 09.05.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Executive Chairman of the BoardSteven Lund7201.01.1996
President, Chief Executive Officer, DirectorRyan Napierski5201.09.202108.09.2015
Interim Chief Financial OfficerChelsea Lantz4218.03.202618.03.2026
Executive Vice President, Chief Operating Officer, Chief Legal OfficerChayce Clark4305.03.202601.08.2021
Executive Vice President, Chief Product OfficerSteven Hatchett54
Executive Vice President and President of Global SalesJustin Keisel52